Skip to main content

Table 3 The distribution of resistance phenotypes among Escherichiacoli isolates from pups in two kennels (A and B).

From: Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels

Resistance patternsa

No. of resistant isolates (%)/No. of pups that harboured resistant isolate (s) (%)

 

Total

Kennel A

Kennel B

 

(n = 86/43)

(n = 50/25)

(n = 36/18)

AMP-CFZ-CFT-OTC-CHL-NAL-ENR

5 (5.8)/3 (7.0)

0 (0)/0 (0)

5 (13.9)/3 (16.7)

AMP-DHS-GEN-KAN-OTC-CHL-SXT

3 (3.5)/2 (4.7)

3 (6.0)/2 (8.0)

0 (0)/0 (0)

AMP-DHS-GEN-OTC-CHL-NAL-SXT

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

AMP-DHS-GEN-OTC-CHL-SXT

11 (12.8)/9 (20.9)

11 (22.0)/9 (36.0)

0 (0)/0 (0)

AMP-DHS-GEN-CHL-SXT

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

AMP-DHS-OTC-SXT

2 (2.3)/1 (2.3)

2 (4.0)/1 (4.0)

0 (0)/0 (0)

AMP-DHS-CHL-SXT

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

AMP-DHS-SXT

16 (18.6)/13 (30.2)

8 (16.0)/8 (32.0)

8 (22.2)/5 (27.8)

AMP-DHS-CHL

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

AMP-DHS

10 (11.6)/6 (14.0)

0 (0)/0 (0)

10 (27.8)/6 (33.3)

DHS-SXT

1 (1.2)/1 (2.3)

0 (0)/0 (0)

1 (2.8)/1 (5.6)

AMP

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

DHS

10 (11.6)/7 (16.3)

7 (14.0)/5 (20.0)

3 (8.3)/2 (11.1)

OTC

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

NAL

1 (1.2)/1 (2.3)

1 (2.0)/1 (4.0)

0 (0)/0 (0)

Susceptible

21 (24.4)/13 (30.2)

12 (24.0)/7 (28.0)

9 (25.0)/6 (33.3)

  1. aAMP, ampicillin; CFZ, cefazolin; CEF, ceftiofur; DHS, dihydrostreptomycin; GEN, gentamicin; KAN, kanamycin; OTC, oxytetracycline; CHL, chloramphenicol; NAL, nalidixic acid; ENR, enrofloxacin; SXT, trimethoprim-sulfamethoxazole.